Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 November 2023 | Story Cindé Greyling | Photo SUPPLIED
Student Athletes
The KovsieSport and SCD teams and student-athletes during the Project Empower and GROW certificate and celebration ceremony.

In the latter part of 2023, KovsieSport (KS) Soccer, in collaboration with Student Counselling and Development (SCD) at the University of the Free State (UFS), introduced a transformative self-development initiative for student-athletes. The GROW programme, an acronym for growth, resilience, optimism, and wellness, is a meticulously structured, resilience-based project firmly rooted in Positive Psychology (PP). PP methodologies aim to foster human strengths, psychological capabilities, and overall flourishing. 

Cultivating an optimised mind for an optimised body 

Dr Munita Dunn-Coetzee, Director of SCD, emphasises the critical link between physical and mental well-being for student-athletes. Pushing their bodies to excel significantly influences their mental health,” she notes. “Creating awareness and a supportive culture within sports teams is important.”  The GROW programme, initially piloted by students four years ago on the Bloemfontein and Qwaqwa campuses, demonstrated statistically significant improvements in students’ subjective well-being, resilience, hope, and noteworthy reductions in experiences of depression and stress. Encouraged by these positive outcomes, the programme was subsequently integrated into KovsieSport. 

Balancing the equation: The other side of sport

Tobias van den Bergh, Senior Psychologist: SCD, underscores the multifaceted nature of well-being. While physical exercise is a potent natural medicine supporting mental health, he highlights the importance of addressing emotional, spiritual, cognitive, social, and physical aspects of well-being. Van den Bergh cautions against the potential harm associated with exercise when linked to high-pressure performance goals or unhealthy objectives, advocating instead for a holistic approach to well-being. 

Bridging the gap: Impact of the GROW programme

The GROW programme successfully bridges the gap between sports and mental health, fostering increased trust among student-athletes. Godfrey Tenoff, Senior Official at KS Football, observes enhanced cohesion among participants, affirming that the programme positively influenced their preparedness for life’s challenges. Makhaola Mohale, one of the attendees, encapsulates the sentiment, stating, “The biggest takeaway was to always have a heart and mind of gratitude.”

Celebrating victories: Stop at the top

On 27 October 2023, the GROW Certificate and Celebration Ceremony acknowledged student-athletes who completed the project, the event served as a reminder that, beyond the pursuit of victories in sports, investing in mental health is a significant triumph. In the words of the author, “Congratulations to all our student-athletes who completed the GROW-programme.”

UFS Student Careline:

  • 0800 00 6363
  • Text: 43302

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept